Hong Kong Stock Movement | BeiGene (06160.HK) rose over 4% in early trading after reaching a clinical collaboration with Revolution Medicines, which will accelerate the development progress in the RAS pathway.
Zhiyu Finance APP learned that BeiGene (06160.HK) rose over 4% in the early trading session. As of this writing, it has increased by 2.72%, reaching HKD 219, with a trading volume of HKD 297 million.
Latest
2 m ago
